Position in RARE
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$5,152,190
-$86,250,500 QoQ
Shares Held
245,928
-93.8% QoQ
Ownership
0.250%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 85.30220227058327.ToString("F0")%
Shared 0.ToString("F0")%
None 14.69779772941674.ToString("F0")%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,578,690,346 across 405 Biotechnology names. RARE ranks #97 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in RARE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,152,190 | 245,928 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $91,402,690 | 3,974,030 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $120,663,782 | 4,011,429 | Shares | Other | 2025-11-26 | |
| 2025-06-30 | $118,565,158 | 3,260,868 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $11,205,941 | 309,471 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $8,657,457 | 205,787 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $11,843,813 | 213,210 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $9,084,124 | 221,025 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $11,773,348 | 252,160 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $13,291,185 | 277,942 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $9,824,817 | 275,591 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $14,445,377 | 313,145 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $11,591,625 | 289,068 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $13,674,529 | 295,155 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $12,951,844 | 312,771 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $17,597,133 | 294,957 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $21,869,003 | 301,143 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $27,039,474 | 321,554 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $27,981,535 | 310,251 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $33,460,125 | 350,919 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $34,895,697 | 306,479 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $32,036,853 | 231,430 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $15,285,200 | 185,974 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $11,663,147 | 149,107 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $4,963,273 | 111,710 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||